Biosimilars and Patients with Inflammatory Bowel Disease
Biosimilars and Patients with Inflammatory Bowel Disease
Array
Activity Info
Test your skills in 3 cases commonly seen in the GI clinic presented by Catherine Bauer, MSN, RN. Kenneth McQuaid, MD, answers common questions about when to prescribe and when to switch patients to a biosimilar. Edward Li, PharmD, compares the efficacy of biosimilars to their reference drugs.